Table: begin end state 1 16 cytoplasmic 17 35 transmembrane 36 39 non-cytoplasmic 40 60 transmembrane 61 93 cytoplasmic 94 119 transmembrane 120 124 non-cytoplasmic 125 146 transmembrane 147 153 cytoplasmic 154 177 transmembrane 178 196 non-cytoplasmic 197 219 transmembrane 220 239 cytoplasmic 240 260 transmembrane 261 273 non-cytoplasmic 274 299 transmembrane 300 330 cytoplasmic 331 353 transmembrane 354 358 non-cytoplasmic 359 380 transmembrane 381 400 cytoplasmic 401 423 transmembrane 424 428 non-cytoplasmic 429 448 transmembrane 449 461 cytoplasmic
Input: >1937132 MADNKPELQRGLEARHIELIALGGTIGVGLFMGAASTLKWAGPSVLLAYIIAGLFVFFIM RSMGEMLFLEPVTGSFAVYAHRYMSPFFGYLTAWSYWFMWMAVGISEITAIGVYVQFWFP EMAQWIPALIAVALVALANLAAVRLYGEIEFWFAMIKVTTIIVMIVIGLGVIFFGFGNGG QSIGFSNLTEHGGFFAGGWKGFLTALCIVVASYQGVELIGITAGEAKNPQVTLRSAVGKV LWRILIFYVGAIFVIVTIFPWNEIGSNGSPFVLTFAKIGITAAAGIINFVVLTAALSGCN SGMYSCGRMLYALAKNRQLPAAMAKVSRHGVPVAGVAVSIAILLIGSCLNYIIPNPQRVF VYVYSASVLPGMVPWFVILISQLRFRRAHKAAIASHPFRSILFPWANYVTMAFLICVLIG MYFNEDTRMSLFVGIIFMLAVTAIYKVFGLNRHGKAHKLEE
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server